Kirkwood JM - Search Results

1

High frequency of brain metastases after adjuvant therapy for high-risk melanoma.

Samlowski WE, Moon J, Witter M, Atkins MB, Kirkwood JM, Othus M, Ribas A, Sondak VK, Flaherty LE. Samlowski WE, et al. Among authors: kirkwood jm. Cancer Med. 2017 Nov;6(11):2576-2585. doi: 10.1002/cam4.1223. Epub 2017 Oct 10. Cancer Med. 2017. PMID: 28994212 Free PMC article. Clinical Trial.

2

Role of interferons in the therapy of melanoma.

Kirkwood JM, Ernstoff MS. Kirkwood JM, et al. J Invest Dermatol. 1990 Dec;95(6 Suppl):180S-184S. doi: 10.1111/1523-1747.ep12875497. J Invest Dermatol. 1990. PMID: 1701805 Free article. Review.

3

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Among authors: kirkwood jm. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

4

Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.

Wadler S, Lembersky B, Atkins M, Kirkwood J, Petrelli N. Wadler S, et al. J Clin Oncol. 1991 Oct;9(10):1806-10. doi: 10.1200/JCO.1991.9.10.1806. J Clin Oncol. 1991. PMID: 1919631 Clinical Trial.

5

Studies of interferons in the therapy of melanoma.

Kirkwood JM. Kirkwood JM. Semin Oncol. 1991 Oct;18(5 Suppl 7):83-90. Semin Oncol. 1991. PMID: 1948134 Review.

6

Interferon alpha-2a and dacarbazine in melanoma.

Kirkwood JM, Ernstoff MS, Giuliano A, Gams R, Robinson WA, Costanzi J, Pouillart P, Speyer J, Grimm M, Spiegel R. Kirkwood JM, et al. J Natl Cancer Inst. 1990 Jun 20;82(12):1062-3. doi: 10.1093/jnci/82.12.1062. J Natl Cancer Inst. 1990. PMID: 2189999 Clinical Trial. No abstract available.

7

High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma.

Luger SM, Kirkwood JM, Ernstoff MS, Vlock DR. Luger SM, et al. Among authors: kirkwood jm. J Natl Cancer Inst. 1990 Dec 19;82(24):1934-7. doi: 10.1093/jnci/82.24.1934. J Natl Cancer Inst. 1990. PMID: 2250315 Clinical Trial. No abstract available.

8

High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy.

Vlock DR, Kirkwood JM, Leutzinger C, Kapp DS, Fischer JJ. Vlock DR, et al. Among authors: kirkwood jm. Cancer. 1982 Jun 1;49(11):2289-94. doi: 10.1002/1097-0142(19820601)49:11<2289::aid-cncr2820491115>3.0.co;2-8. Cancer. 1982. PMID: 7074545

9

The role of interferons in the therapy of melanoma.

Kirkwood JM. Kirkwood JM. Immunol Ser. 1994;61:239-50. Immunol Ser. 1994. PMID: 7516716 Review. No abstract available.

10

Systemic therapy of melanoma.

Kirkwood JM. Kirkwood JM. Curr Opin Oncol. 1994 Mar;6(2):204-11. doi: 10.1097/00001622-199403000-00014. Curr Opin Oncol. 1994. PMID: 8011698 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

600 results

Search Page